MiR-320a as a Potential Novel Circulating Biomarker of Arrhythmogenic CardioMyopathy
Abstract Diagnosis of Arrhythmogenic CardioMyopathy (ACM) is challenging and often late after disease onset. No circulating biomarkers are available to date. Given their involvement in several cardiovascular diseases, plasma microRNAs warranted investigation as potential non-invasive diagnostic tool...
Guardado en:
Autores principales: | Elena Sommariva, Yuri D’Alessandra, Floriana Maria Farina, Michela Casella, Fabio Cattaneo, Valentina Catto, Mattia Chiesa, Ilaria Stadiotti, Silvia Brambilla, Antonio Dello Russo, Corrado Carbucicchio, Giulia Vettor, Daniela Riggio, Maria Teresa Sandri, Andrea Barbuti, Gianluca Vernillo, Manuela Muratori, Matteo Dal Ferro, Gianfranco Sinagra, Silvia Moimas, Mauro Giacca, Gualtiero Ivanoe Colombo, Giulio Pompilio, Claudio Tondo |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e26e274e01914cf2a070af4986535dc0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Efficacy of Catheter Ablation for Atrial Arrhythmias in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy—A Multicenter Study
por: Alessio Gasperetti, et al.
Publicado: (2021) -
Arrhythmogenic effects of hypoglycemia
por: Dmitriy Nikitich Laptev, et al.
Publicado: (2012) -
Arrhythmogenic Remodeling in the Failing Heart
por: Zoltán Husti, et al.
Publicado: (2021) -
Acta Nº320
por: Banco Central de Chile
Publicado: (2019) -
Evolving Diagnostic Criteria for Arrhythmogenic Cardiomyopathy
por: Domenico Corrado, et al.
Publicado: (2021)